201 related articles for article (PubMed ID: 22983022)
1. CHADS(2) and CHA(2)DS (2)-VASc score of patients with atrial fibrillation or flutter and newly detected left atrial thrombus.
Wasmer K; Köbe J; Dechering D; Milberg P; Pott C; Vogler J; Stypmann J; Waltenberger J; Mönnig G; Breithardt G; Eckardt L
Clin Res Cardiol; 2013 Feb; 102(2):139-44. PubMed ID: 22983022
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of transesophageal echocardiography to confirm clinical utility of CHA2DS2-VASc and CHADS2 scores in atrial flutter.
Parikh MG; Aziz Z; Krishnan K; Madias C; Trohman RG
Am J Cardiol; 2012 Feb; 109(4):550-5. PubMed ID: 22133753
[TBL] [Abstract][Full Text] [Related]
3. Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.
Mason PK; Lake DE; DiMarco JP; Ferguson JD; Mangrum JM; Bilchick K; Moorman LP; Moorman JR
Am J Med; 2012 Jun; 125(6):603.e1-6. PubMed ID: 22502952
[TBL] [Abstract][Full Text] [Related]
4. Correlation of CHADS2 and CHA2DS2-VASc scores with transesophageal echocardiography risk factors for thromboembolism in a multiethnic United States population with nonvalvular atrial fibrillation.
Willens HJ; Gómez-Marín O; Nelson K; DeNicco A; Moscucci M
J Am Soc Echocardiogr; 2013 Feb; 26(2):175-84. PubMed ID: 23253435
[TBL] [Abstract][Full Text] [Related]
5. CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients.
Naccarelli GV; Panaccio MP; Cummins G; Tu N
Am J Cardiol; 2012 May; 109(10):1526-33. PubMed ID: 22360819
[TBL] [Abstract][Full Text] [Related]
6. Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2 DS2 -VASc scores.
Cha MJ; Kim YD; Nam HS; Kim J; Lee DH; Heo JH
Eur J Neurol; 2012 Mar; 19(3):473-9. PubMed ID: 21972975
[TBL] [Abstract][Full Text] [Related]
7. Comparison between CHADS2 and CHA2 DS2 -VASc score in a stroke cohort with atrial fibrillation.
Giralt-Steinhauer E; Cuadrado-Godia E; Ois A; Jiménez-Conde J; Rodríguez-Campello Á; Soriano C; Roquer J
Eur J Neurol; 2013 Apr; 20(4):623-8. PubMed ID: 22834861
[TBL] [Abstract][Full Text] [Related]
8. Stroke due to atrial fibrillation in a population-based stroke registry (Ludwigshafen Stroke Study) CHADS(2) , CHA(2) DS(2) -VASc score, underuse of oral anticoagulation, and implications for preventive measures.
Palm F; Kleemann T; Dos Santos M; Urbanek C; Buggle F; Safer A; Hennerici MG; Becher H; Zahn R; Grau AJ
Eur J Neurol; 2013 Jan; 20(1):117-23. PubMed ID: 22788384
[TBL] [Abstract][Full Text] [Related]
9. Detection of left atrial thrombus during routine diagnostic work-up prior to pulmonary vein isolation for atrial fibrillation: role of transesophageal echocardiography and multidetector computed tomography.
Dorenkamp M; Sohns C; Vollmann D; Lüthje L; Seegers J; Wachter R; Puls M; Staab W; Lotz J; Zabel M
Int J Cardiol; 2013 Feb; 163(1):26-33. PubMed ID: 21764466
[TBL] [Abstract][Full Text] [Related]
10. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Prostran MS; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):319-26. PubMed ID: 22319004
[TBL] [Abstract][Full Text] [Related]
11. Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
Lip GY; Connolly S; Yusuf S; Shestakovska O; Flaker G; Hart R; Lanas F; Xavier D; Eikelboom J;
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):31-8. PubMed ID: 23390125
[TBL] [Abstract][Full Text] [Related]
12. Possible refinement of clinical thromboembolism assessment in patients with atrial fibrillation using echocardiographic parameters.
Providência R; Botelho A; Trigo J; Quintal N; Nascimento J; Mota P; Leitão-Marques A
Europace; 2012 Jan; 14(1):36-45. PubMed ID: 21868410
[TBL] [Abstract][Full Text] [Related]
13. CHA(2)DS(2)-VASc versus CHADS(2) for stroke risk assessment in low-risk patients with atrial fibrillation: a pilot study from a single center of the NCDR-PINNACLE registry.
Piyaskulkaew C; Singh T; Szpunar S; Saravolatz L; Rosman H
J Thromb Thrombolysis; 2014 May; 37(4):400-3. PubMed ID: 23943340
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics of left atrial appendage thrombus in patients with hypertrophic cardiomyopathy and non-valvular atrial fibrillation].
Cui J; Du X; Wu JH; Jia CQ; Ruan YF; Ning M; Hu R; Lyu J; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Dec; 47(12):956-962. PubMed ID: 31877590
[No Abstract] [Full Text] [Related]
15. Early neurological outcomes according to CHADS2 score in stroke patients with non-valvular atrial fibrillation.
Hong HJ; Kim YD; Cha MJ; Kim J; Lee DH; Lee HS; Nam CM; Nam HS; Heo JH
Eur J Neurol; 2012 Feb; 19(2):284-90. PubMed ID: 21914056
[TBL] [Abstract][Full Text] [Related]
16. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation.
Chao TF; Lin YJ; Tsao HM; Tsai CF; Lin WS; Chang SL; Lo LW; Hu YF; Tuan TC; Suenari K; Li CH; Hartono B; Chang HY; Ambrose K; Wu TJ; Chen SA
J Am Coll Cardiol; 2011 Nov; 58(23):2380-5. PubMed ID: 22115643
[TBL] [Abstract][Full Text] [Related]
17. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.
Olesen JB; Lip GY; Hansen ML; Hansen PR; Tolstrup JS; Lindhardsen J; Selmer C; Ahlehoff O; Olsen AM; Gislason GH; Torp-Pedersen C
BMJ; 2011 Jan; 342():d124. PubMed ID: 21282258
[TBL] [Abstract][Full Text] [Related]
18. Can we predict stroke in atrial fibrillation?
Lip GY
Clin Cardiol; 2012 Jan; 35 Suppl 1(Suppl 1):21-7. PubMed ID: 22246948
[TBL] [Abstract][Full Text] [Related]
19. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation.
Scherr D; Dalal D; Chilukuri K; Dong J; Spragg D; Henrikson CA; Nazarian S; Cheng A; Berger RD; Abraham TP; Calkins H; Marine JE
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):379-84. PubMed ID: 19017348
[TBL] [Abstract][Full Text] [Related]
20. The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.
Coppens M; Eikelboom JW; Hart RG; Yusuf S; Lip GY; Dorian P; Shestakovska O; Connolly SJ
Eur Heart J; 2013 Jan; 34(3):170-6. PubMed ID: 23018151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]